SEC Form 3 · accession 0001493152-17-003307
VBI Vaccines Inc/BC · VBIV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Catherine Eckenswiller
Officer — Contracts and IP Counsel
Period of report
Dec 31, 2016
Accepted (ET)
Mar 31, 2017 · 8:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000764195
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, no par value per share | holding | — | — | — | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (Right to Buy Common Shares)F2,F1 | $3.80 | holding | — | — | — | — | Sep 23, 2026 | Common Shares | 10,000 | — | D |
Explanation of responses
- F1The option vests 1/48th of the total shares monthly following the grant date September 23, 2016, subject to continued service through each vesting date.
- F2Exercise price is in Canadian dollars, United States dollars equivalent is shown using the closing foreign exchange rate on September 23, 2016, which was the date the option was granted.